Back
Cue Biopharma Vs. GlycoMimetics Industry Stock Comparison
Buy
75
CUE
Cue Biopharma
Last Price:
1.68
Seasonality Move:
27.28%
Buy
54
GLYC
GlycoMimetics
Last Price:
0.49
Seasonality Move:
50.06%
Buy
75
Cue Biopharma (CUE)
is a Buy
Is Cue Biopharma a Buy, Sell or Hold?
- The current Cue Biopharma [CUE] share price is $1.78. The Score for CUE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- CUE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
GlycoMimetics (GLYC)
is a Buy
Is GlycoMimetics a Buy, Sell or Hold?
- The current GlycoMimetics [GLYC] share price is $0.17. The Score for GLYC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- GLYC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CUE Stock Price Chart
What is Cue Biopharma's stock price today?
-
The Cue Biopharma share price today is $1.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CUE is experiencing buying pressure, which is a positive indicator for future bullish movement.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLYC is experiencing selling pressure, which indicates risk of future bearish movement.
CUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.23 | Buy |
Relative Strength Index (14 RSI): | 71.61 | Buy |
Chaikin Money Flow: | 514836 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.7 - 1.5) | Buy |
Bollinger Bands (100): | (0.6 - 1.3) | Buy |
GLYC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 53.49 | Buy |
Chaikin Money Flow: | -967323 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.15 - 0.17) | Buy |
Bollinger Bands (100): | (0.15 - 0.27) | Sell |
CUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.49 | Buy |
20-day SMA: | 1.24 | Buy |
50-day SMA: | 0.88 | Buy |
200-day SMA: | 1.49 | Buy |
8-day EMA: | 1.52 | Buy |
20-day EMA: | 1.28 | Buy |
50-day EMA: | 1.04 | Buy |
200-day EMA: | 1.45 | Buy |
GLYC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.17 | Buy |
20-day SMA: | 0.16 | Buy |
50-day SMA: | 0.17 | Buy |
200-day SMA: | 1.22 | Sell |
8-day EMA: | 0.17 | Buy |
20-day EMA: | 0.16 | Buy |
50-day EMA: | 0.19 | Sell |
200-day EMA: | 0.81 | Sell |
Cue Biopharma Earnings Growth & CUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.07 per share.
GlycoMimetics Earnings Growth & GLYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.12 per share.
Cue Biopharma Technical Analysis
Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
GlycoMimetics Technical Analysis
Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |